MPI – Interim Report First Half 2016

Hoersholm; August 31st 2016 – Medical Prognosis Institute A/S (MPI) announces the Company’s Interim Report First Half 2016.


Interim Report First Half 2016

The Board of Directors for Medical Prognosis Institute A/S has today discussed and approved the Interim Report First Half 2016.

Please find the full Interim report on

For further information, please contact
Peter Buhl Jensen, CEO
e-mail: [email protected]
Cell Phone: +45 21 60 89 22

This information is information that Medical Prognosis Institute A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 31st August 2016.

Certified Advisor: Sedermera Fondkommission, Norra Vallgatan 64, 211 22, Malmö, Sweden

Sign up for press releases and receive relevant information about Allarity Therapeutics A/S